HCW Biologics Inc.
HCWB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 138.3% | 29.3% | -98.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -1,094.3% | 20% | 20% | 20% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $2 | $0 | $2 |
| SG&A Expenses | $2 | $2 | $0 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $3 | $3 | $2 | $3 |
| Operating Income | -$3 | -$3 | -$2 | -$3 |
| % Margin | -21,056.8% | -52,886.7% | -38,811.5% | -800.3% |
| Other Income/Exp. Net | -$1 | $2 | -$0 | -$0 |
| Pre-Tax Income | -$5 | -$2 | -$2 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$2 | -$2 | -$3 |
| % Margin | -29,183.2% | -29,431% | -43,373.6% | -854.4% |
| EPS | -2.02 | -6.79 | -0.05 | -0.08 |
| % Growth | 70.3% | -13,480% | 37.5% | – |
| EPS Diluted | -2.02 | -6.79 | -0.05 | -0.08 |
| Weighted Avg Shares Out | 2 | 2 | 45 | 39 |
| Weighted Avg Shares Out Dil | 2 | 2 | 45 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$4 | -$1 | -$1 | -$2 |
| % Margin | -27,254.7% | -19,921.4% | -24,659.1% | -485.1% |